Sonio

Sonio, a visionary player in the AI and Health Care industries, is revolutionizing prenatal care with its flagship product. The company's slogan, "Securing pregnancy care," underscores its commitment to enhancing the quality and efficiency of prenatal examinations. Established in 2020, Sonio has developed a highly customizable workflow solution powered by AI to assist ultrasound practitioners in performing high-quality prenatal diagnostic procedures. This advanced solution ensures examinations are thorough, integrates seamlessly into practitioners' workflows, and elevates prenatal diagnosis standards.

Based in the United States, Sonio boasts significant backing and validation, underscored by its acquisition by Samsung Medison Co., Ltd in 2024 for a substantial $92.70M. The acquisition marks a strategic investment by Samsung Medison, emphasizing confidence in Sonio's technology and potential market impact. With over five years of foundational research and expert collaboration, Sonio is poised to continue leading advancements in medical devices and prenatal healthcare.